Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|7|696-701

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.7, 2015-07, pp. : 696-701

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. S1, 2015-04 ,pp. : 2-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer immunotherapy

By Baxevanis Constantin N.   Perez Sonia A.   Papamichail Michael  

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 4, 2009-08 ,pp. : 167-189

Informa Healthcare

Access to resources Recommend Favorite

Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?

By  

Oncology Research and Treatment, Vol. 33, Iss. 3, 2010-02 ,pp. : 101-105

Karger

Access to resources Recommend Favorite

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Immunotherapy drug improves survival of patients with squamous non–small cell lung cancer

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3562-3563

John Wiley & Sons Inc

Access to resources Recommend Favorite